Nightly Business Report — July 25, 2014

Tonight on Nightly Business Report, stocks end the week lower, but will a jam-packed economic agenda next week change sentiment?
And, why Sovaldi, the breakthrough Hepatitis C drug, is creating a big headache for both states and health insurers.

This entry was posted in NBR Shows. Bookmark the permalink.

Leave a Reply